Charges Against Former Hedge Fund Portfolio Manager for $276 Million Insider Trading Scheme Involving Alzheimer’s Disease Drug Trial
Nov. 20, 2012
http://www.fbi.gov/newyork/press-releases/2012/manhattan-u.s.-attorney-and-fbi-special-agent-in-charge-announce-charges-against-former-hedge-fund-portfolio-manager-for-276-million-insider-trading-scheme-involving-alzheimers-disease-drug-trial?utm_campaign=email-Immediate&utm_medium=email&utm_source=new-york-press-releases&utm_content=155344